Market Research Logo

Pharmaceuticals in Europe

Pharmaceuticals in Europe

Summary

Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Europe pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The European pharmaceuticals market had total revenues of $265.9bn in 2017, representing a compound annual growth rate (CAGR) of 3.4% between 2013 and 2017.
  • In many European countries, an aging population and the diseases associated with this have driven growth in the pharmaceutical market.
  • Expansion in Europe is limited by increasing focus upon the use of generic drugs by healthcare systems across the region. France, in particular, is placing public stress on capping costs through avoiding branded drugs.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Europe
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the Europe pharmaceuticals market by value in 2017?
  • What will be the size of the Europe pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the Europe pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Europe's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Johnson & Johnson
Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Europe pharmaceuticals market value: $ billion, 2013-17
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Europe pharmaceuticals market share: % share, by value, 2017
Table 4: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: key financials ($)
Table 7: Johnson & Johnson: key financial ratios
Table 8: Novartis AG: key facts
Table 9: Novartis AG: key financials ($)
Table 10: Novartis AG: key financial ratios
Table 11: Pfizer Inc.: key facts
Table 12: Pfizer Inc.: key financials ($)
Table 13: Pfizer Inc.: key financial ratios
Table 14: F. Hoffmann-La Roche Ltd: key facts
Table 15: F. Hoffmann-La Roche Ltd: key financials ($)
Table 16: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 17: F. Hoffmann-La Roche Ltd: key financial ratios
List of Figures
Figure 1: Europe pharmaceuticals market value: $ billion, 2013-17
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Europe pharmaceuticals market share: % share, by value, 2017
Figure 4: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in Europe, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in Europe, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in Europe, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2017
Figure 11: Johnson & Johnson: revenues & profitability
Figure 12: Johnson & Johnson: assets & liabilities
Figure 13: Novartis AG: revenues & profitability
Figure 14: Novartis AG: assets & liabilities
Figure 15: Pfizer Inc.: revenues & profitability
Figure 16: Pfizer Inc.: assets & liabilities
Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report